1. Home
  2. GEOS vs RNAC Comparison

GEOS vs RNAC Comparison

Compare GEOS & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • RNAC
  • Stock Information
  • Founded
  • GEOS 1980
  • RNAC 2007
  • Country
  • GEOS United States
  • RNAC United States
  • Employees
  • GEOS N/A
  • RNAC N/A
  • Industry
  • GEOS Industrial Machinery/Components
  • RNAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEOS Industrials
  • RNAC Health Care
  • Exchange
  • GEOS Nasdaq
  • RNAC Nasdaq
  • Market Cap
  • GEOS 249.9M
  • RNAC 276.3M
  • IPO Year
  • GEOS 1997
  • RNAC 2016
  • Fundamental
  • Price
  • GEOS $22.07
  • RNAC $9.67
  • Analyst Decision
  • GEOS
  • RNAC Strong Buy
  • Analyst Count
  • GEOS 0
  • RNAC 4
  • Target Price
  • GEOS N/A
  • RNAC $40.00
  • AVG Volume (30 Days)
  • GEOS 167.6K
  • RNAC 83.4K
  • Earning Date
  • GEOS 11-20-2025
  • RNAC 11-06-2025
  • Dividend Yield
  • GEOS N/A
  • RNAC N/A
  • EPS Growth
  • GEOS N/A
  • RNAC N/A
  • EPS
  • GEOS N/A
  • RNAC N/A
  • Revenue
  • GEOS $115,527,000.00
  • RNAC $1,026,000.00
  • Revenue This Year
  • GEOS N/A
  • RNAC N/A
  • Revenue Next Year
  • GEOS N/A
  • RNAC N/A
  • P/E Ratio
  • GEOS N/A
  • RNAC N/A
  • Revenue Growth
  • GEOS N/A
  • RNAC N/A
  • 52 Week Low
  • GEOS $5.51
  • RNAC $8.46
  • 52 Week High
  • GEOS $22.64
  • RNAC $26.50
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 64.19
  • RNAC 44.74
  • Support Level
  • GEOS $16.46
  • RNAC $9.87
  • Resistance Level
  • GEOS $20.98
  • RNAC $10.48
  • Average True Range (ATR)
  • GEOS 1.40
  • RNAC 0.62
  • MACD
  • GEOS 0.07
  • RNAC 0.07
  • Stochastic Oscillator
  • GEOS 79.58
  • RNAC 41.25

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: